Dr. Andrew von Eschenbach won the backing of a U.S. Senate panel to head the FDA, sending his nomination to the Senate floor, where the outcome is in doubt. The nomination now faces a block on the floor vote by two Republican senators as the current congressional session winds down.

Related Summaries